<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>International Journal of Molecular and Cellular Medicine</title>
<title_fa>مجله بین المللی سلولی و مولکولی</title_fa>
<short_title>Int J Mol Cell Med</short_title>
<subject>Medical Sciences</subject>
<web_url>http://ijmcmed.org</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>2251-9637</journal_id_issn>
<journal_id_issn_online>2251-9645</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi>10.22088/IJMCM.BUMS</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid></journal_id_sid>
<journal_id_nlai></journal_id_nlai>
<journal_id_science></journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1404</year>
	<month>4</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2025</year>
	<month>7</month>
	<day>1</day>
</pubdate>
<volume>14</volume>
<number>2</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Colorectal Cancer; Novel Approaches in Chimeric Antigen Receptors (CAR) -T cell</title>
	<subject_fa>Cancer</subject_fa>
	<subject>Cancer</subject>
	<content_type_fa>Review</content_type_fa>
	<content_type>Review</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;p&gt;&lt;span style=&quot;font-size:12px;&quot;&gt;&lt;span style=&quot;font-family:Tahoma;&quot;&gt;&lt;span style=&quot;line-height:14.0pt&quot;&gt;&lt;span style=&quot;color:#231f20&quot;&gt;Colorectal cancer (CRC) is a popular type of cancer, characterized by high mortality and a notable impression on the well-being of individuals. The success of adoptive chimeric antigen receptor T (CAR-T) cell therapy in treating hematological malignancies has been remarkable in recent years; however, its application in solid tumors like CRC has many challenges. &lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&lt;span style=&quot;line-height:14.0pt&quot;&gt;&lt;span style=&quot;color:#231f20&quot;&gt;These obstacles encompass the immunosuppressive microenvironment of the tumor, the insufficient targeting of CAR-T cells, the limited lifespan of CAR-T cells within the body, and the constrained capacity for proliferation. Additionally, CAR-T cells face hurdles in effectively infiltrating the tumor site, which further complicates treatment outcomes. Diverse innovative strategies have been suggested to surmount these barriers in the context of CRC. &lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&lt;span style=&quot;line-height:14.0pt&quot;&gt;&lt;span style=&quot;color:#231f20&quot;&gt;This comprehensive review endeavors to meticulously elucidate an exhaustive and detailed evaluation of the prevailing and contemporary landscape concerning CAR-T cell therapy as it pertains to the intricate management of CRC, while simultaneously offering a thorough indication of the various risk factors and the associated prevalence that are intricately linked with the manifestation and progression of CRC.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Colorectal cancer, CAR-T cell, Treatment approaches</keyword>
	<start_page>777</start_page>
	<end_page>792</end_page>
	<web_url>http://ijmcmed.org/browse.php?a_code=A-10-8020-2&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Mahyar</first_name>
	<middle_name></middle_name>
	<last_name>Haki</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>Mahyar.haki@gmail.com</email>
	<code>100319475328460034502</code>
	<orcid>0009-0007-0775-4795</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Biomedical Engineering Department, Amirkabir University of Technology (Tehran Polytechnic), Tehran, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Mohammad</first_name>
	<middle_name></middle_name>
	<last_name>Darvishi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>darvishi1349@gmail.com</email>
	<code>100319475328460034503</code>
	<orcid>100319475328460034503</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>School of Aerospace and Subaquatic Medicine, Infectious Diseases Research Center, Beasat Hospital, AJA University of Medical Sciences, Tehran, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
